EPM News Update
Theorem Clinical Research has won recognition in all five categories of the 2014 CRO Leadership Awards: Quality, Productivity, Reliability, Innovation and Regulatory.
“Theorem is committed to retaining therapeutic thought leaders and expert support staff to build tightly integrated partnerships with our clients and provide expert guidance and thorough communication,” said John Potthoff, Theorem president and CEO. “We are proud to have been recognised by our peers for our work in clinical research.”
The CRO Leadership Awards are presented by Life Science Leader magazine and based on industry research conducted by Nice Insight. Companies receiving scores in the top 20th percentile in each category were recognised for their achievements. Unlike other industry awards that are based on a subjective nomination and voting process, the CRO Leadership Awards are based on objective research conducted among pharmaceutical and biopharmaceutical companies utilising contract research services. The awards provide pharma companies with additional information to use to vet potential partners.
Specifically, the awards recognised Theorem’s abilities to deliver agreed objectives and to meet timelines. Theorem was also recognised for treating clients’ projects as if they were their own, for enhancing clients’ in-house capabilities through new ideas and for being reputable and compliant.
“These awards recognise the hard work and dedication of the entire Theorem team,” Potthoff said. “I couldn’t be prouder of their accomplishments.”
Theorem Clinical Research Inc., www.theoremclinical.com.